It is pertinent to note that genetic mutations in carnitine-acylcarnitine translocase (encoded by SLC25A20), which mediates the transport of acylcarnitines into the mitochondrial matrix, cause severe metabolic disorders, including hypoglycemia, myopathy, and muscle weakness in humans (Fukushima et al., 2013; Iacobazzi et al., 2004). This evidence concerns the gene SLC25A20 and Other metabolic disease.